On 29 November, Lumito AB (publ) (“Lumito”) ended the first exercise period for the Series 2 TO2 subscription warrant. The exercise rate was 72.3 percent, at an exercise price of SEK 1.45 per share.
In total, 11,179,281 new shares have been subscribed during the now concluded first exercise period. Lumito is thus provided approximately MSEK 16.2 in proceeds, before issuance costs. The issuance costs are estimated to be approximately MSEK 0.8. The exercise rate was 72.3 percent. The remaining Series 2 TO2 warrants can be exercised during the period 1 May 2020 to 30 May 2020 inclusive, at an exercise price corresponding to SEK 1.55 per share. Trading in warrants will continue.
As soon as the proceeds from all of the newly subscribed shares (interim shares) have been received by the company, and the issue has been finally registered with the Swedish Companies Registration Office, the interim shares will be automatically converted to regular shares without further notice to the holders. This is projected to take place in week 51.
Through this exercise of warrants, the number of shares outstanding in Lumito increases by 11,179,281, to 70,648,739 shares in total. Simultaneously, the share capital increases by SEK 279,482.02, to SEK 1,766,218.48.
“We are grateful for the great trust that our shareholders are placing in us; the capital we are raising now will bring stability to our forthcoming effort to launch our first product,” says Stefan Nilsson, CEO of Lumito.
G&W Fondkommission has acted as financial adviser to Lumito in connection with the transaction.
